Yiying Khor
About Yiying Khor
Yiying Khor is a Process Development Engineer III at Nektar Therapeutics, specializing in combination product design control and container closure integrity methods. With experience at several leading pharmaceutical companies, Khor has a strong background in packaging systems and shipping qualifications.
Work at Nektar Therapeutics
Yiying Khor has been employed at Nektar Therapeutics as a Process Development Engineer III since 2021. In this role, Khor applies expertise in combination product design control processes and container closure integrity (CCI) method development. The position is based in the San Francisco Bay Area, where Khor contributes to the development and qualification processes that support regulatory filings.
Previous Experience in Pharmaceutical Engineering
Prior to joining Nektar Therapeutics, Yiying Khor worked at Genentech as an Engineer II from 2017 to 2021. Khor also held a position as a Senior Engineer at Genentech for a brief period in 2021. Before that, Khor was employed at Amgen, where roles included Engineer from 2015 to 2017 and Associate Engineer from 2013 to 2015. Khor's early career included a position as a Development Engineer at B. Braun Medical in Penang, Malaysia, from 2011 to 2012.
Education and Expertise
Yiying Khor earned a Bachelor of Science (B.Sc.) degree in Chemical Engineering from Iowa State University, studying from 2008 to 2010. Khor specializes in packaging systems and shipping qualification within the pharmaceutical development sector, with a strong focus on regulatory compliance and method development.
Specialization in Container Closure Integrity
Khor possesses in-depth knowledge of container closure integrity (CCI) method development and qualification. This expertise is crucial for ensuring that pharmaceutical products maintain their integrity and safety throughout their lifecycle, particularly in support of regulatory filings.